We need your permission for setting certain cookies to be able to show this content.
You can change your cookie settings.
Simple science summary
Scientists from the University of Groningen discovered that the bacterium that causes tuberculosis uses a strange protein to import vitamin B12. Transport proteins that import substances from the environment are usually selective. But, in addition to vitamin B12, this particular transporter can import very different molecules, including the antibiotic peptide bleomycin. The mystery was solved by analysing the structure of the transport protein using an electron microscope. It turned out that the protein has a large water-filled cavity that spans the entire thickness of the cell membrane, taking anything in the water with it. It is the first time that such a novel, non-selective transport mechanism has been observed. However, the scientists believe that it may be common in bacteria and possibly also in human cells.
A transport protein that is used by the human pathogen Mycobacterium tuberculosis to import vitamin B12 turns out to be very different from other transport proteins. It contains a huge water-filled cavity, in which hydrophilic substances are transported across the cell membrane. This discovery, which changes our understanding of bacterial physiology, was made by imaging the transport protein using cryo-electron microscopy. The results were published in the journal Nature on 26 March.
The tuberculosis bacterium has all the genes required to produce vitamin B12 but, for some reason, it still needs to import this vitamin for successful cell division. To do so, it uses a transport protein that is part of a large family of ATP-binding cassette (ABC) transporters. Interestingly, the vitamin B12 transporter is also implicated in the transport of antimicrobial peptides such as bleomycin. ‘And it is very odd to have a single transporter for two very different types of molecules,’ says Professor of Biochemistry Dirk Slotboom.
Slotboom and his team, together with their colleague Albert Guskov, set out to elucidate the protein structure of the enigmatic transporter. ‘This was a long process but we finally cracked it using cryo-electron microscopy,’ says Slotboom. This was performed at the SLAC National Accelerator Laboratory, Menlo Park, CA, USA. The structure revealed a major surprise: a water-filled cavity that spans the entire cell membrane, measuring a massive 7,700 cubic Ångstrom. ‘That is as big as seven vitamin B12 molecules.’
This cavity appears to simply transport water together with any substances that might be in it. ‘You could compare it with a sluice,’ explains Slotboom. ‘You let the water in and everything that is in it.’ It does explain why the transporter can handle both antibiotic peptides and vitamin B12. Since it is non-selective, it must be an inefficient transport system. This does not matter for the uptake of vitamin B12 by Mycobacterium tuberculosis, as the cells only need to take up very few of these molecules during their reproductive cycle, which lasts around 24 hours.
The non-selective transport system is totally different from known transporters. ‘As such, it changes the way that we look at the physiology of bacteria. There are strong indications that other bacterial species have a similar system, which means that they pick up random molecules from their environment.’ It also offers an interesting perspective on the treatment of tuberculosis: ‘If we could stimulate the activity of this transporter, it might import antibiotics more efficiently, making it easier to kill these cells. We realize, though, that this may not be straightforward, as the bacterium uses effective strategies to keep antibiotics out.’
The next step is to find out how the transporter works. ‘We expect that inside the cell, the sluice is emptied by binding and hydrolysing ATP. But we do not know how it opens on the outside, to let new molecules in.’ The transport protein is a dimer and the two halves appear to protrude on the outside – where they may somehow open up to let fresh cargo in. ‘Maybe we can find a way to loosen this cap and let more antibiotics in.’
There is also a distinct possibility that a similar sluice-type transporter is present in human cells, says Slotboom. In our intestines, vitamin B12 is first bound to a peptide called intrinsic factor and then taken up by epithelial cells. ‘It ends up in lysosomes, vesicles full of enzymes, where the intrinsic factor is degraded. Next, the vitamin B12 is released from the lysosome into the cells. I strongly suspect that this involves a similar non-specific transporter.’
Reference: S. Rempel, C. Gati, M. Nijland, C. Thangaratnarajah, A. Karyolaimos, J. W. de Gier, A. Guskov & D. J. Slotboom: A mycobacterial ABC transporter mediates the uptake of hydrophilic compounds. Nature, 26 March 2020
Thursday 26 March saw the announcement that Jacquelien Scherpen, Professor of Systems and Control Engineering at the University of Groningen, has been appointed as the Captain of Science in the High-Tech Systems and Materials (HTSM) top sector. Prof...
E-bikes, school children on bikes and the elderly in traffic. Professor of Traffic Psychology Karel Brookhuis (himself almost 70) has clear opinions on the subject. Now approaching the end of a long career, he is cautiously stepping down from his soapbox...
The new In Science podcast is all about the coronavirus.
Our guest is Casper Albers, professor in Applied Statistics and Data Visualisation.